• Zachary Ramsay, Rachel Bartlett, Amza Ali, Justin Grant, Georgiana Gordon-Strachan, and Monika Asnani.
• Sickle Cell Unit, Caribbean Institute for Health Research, The University of the West Indies.
• Clin J Pain. 2021 Aug 1; 37 (8): 583590583-590.

ObjectivesAcute pain is the main complication of sickle cell disease. Chronic pain (CP) and neuropathic pain (NP) may also be experienced, but have not been formally described in Jamaican patients. A cross-sectional study was conducted to determine their prevalence and characteristics, and to determine the common pain locations and modalities of management.Materials And MethodsAll well individuals with sickle cell disease patients 14 years and older, not pregnant and without a history of clinical stroke were consecutively recruited. Anthropometric measurements, hematology studies, an analgesia checklist, and the Adult Sickle Cell Quality of Life Measurement Information System questionnaire were completed. The painDETECT questionnaire was completed to describe NP and pain patterns-from which CP was defined.ResultsThere were 257 patients in total, with 55.6% being females; the mean age of the patients was 31.7±12 years, and 75% had the SS genotype. Almost all patients (92.6%) had had an acute pain crisis in their lifetime and 72.4% in the last year. The mean severity at last attack was 6.8±3.1 on a scale of 0 to 10. The prevalences of CP and NP were 21.5% and 17.9%, respectively. Female sex, the presence of current leg ulcers, and the use of a strong opioid in the last 4 weeks produced higher odds of NP, whereas older age, milder genotypes, and daily analgesic use had the highest odds of CP. Opioids were used by 40.1% of the patients in the previous 4 weeks, whereas nonpharmacological treatments such as physiotherapy was less used, but reported to be very effective.DiscussionCP and NP should be assessed during routine care of sickle cell pain so that targeted therapies can be applied.Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

15 keywords...

hide…